Related Experiment Videos
Risk of second primary cancer following differentiated thyroid cancer
Emmanuelle Berthe1, Michel Henry-Amar, Jean-Jacques Michels
1Service de Médecine Nucléaire, CLCC François Baclesse, Avenue Général Harris, 14076, Caen Cedex 05, France.
European Journal of Nuclear Medicine and Molecular Imaging
|January 30, 2004
Summary
Women with differentiated thyroid carcinoma face an increased risk of developing second cancers, particularly in the genitourinary tract and kidneys. Age and prior cancer history are key risk factors, not radiation exposure.
Area of Science:
- Oncology
- Epidemiology
- Genetics
Background:
- Differentiated thyroid carcinoma (DTC) survivors may have an elevated risk of secondary malignancies.
- Iodine-131 ((131)I) and external radiation are potential carcinogens, but their role in second cancer development post-DTC is debated.
- Thyroid cancer is a polygenic disease, potentially linked with other cancers.
Purpose of the Study:
- To investigate the incidence and causes of second cancers in a cohort of DTC patients.
- To identify risk factors associated with second cancer development in DTC survivors.
Main Methods:
- A cohort of 875 DTC patients from Basse-Normandie, France, was analyzed.
- Cancer incidence was compared to the general population using standardized incidence ratios (SIR).
- Life-table methods and Cox regression models were used to estimate cumulative risk and identify correlating factors.
Main Results:
- Over 8 years of follow-up, 58 second cancers were observed.
- Women with DTC showed an increased overall risk of second cancer (SIR=1.52), particularly genitourinary cancers (SIR=3.31) and kidney cancer (SIR=7.02).
- Age over 40 and a history of previous primary cancer were significant risk factors; neither cervical irradiation nor (131)I cumulative activity correlated with risk.
Conclusions:
- DTC patients, especially women, are at increased risk for genitourinary and kidney cancers.
- Age and prior cancer history are primary risk factors for second cancers post-DTC.
- Further research should consider common environmental/genetic factors and long-term treatment effects.